How is the Halozyme Therapeutics Inc. today?

The Halozyme Therapeutics Inc. today is trading in the down by -1.75% at 64.02.

Halozyme Therapeutics Inc. XNAS: HALO

Halozyme Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Halozyme Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Halozyme Therapeutics Inc.
Rating: 3.27570825
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

Download real time

64.02 -1.14 (-1.75%)

New 52W High today

2.4M XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)

High Financial Strength

83.3 / 100

Mid Valuation

31.5 / 100

Technically Moderately Bullish

63.9 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM

66

1Yr Price target upside is 3%

9 analysts

Halozyme Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Halozyme Therapeutics Inc. FAQ

How is Halozyme Therapeutics Inc. today?

Halozyme Therapeutics Inc. today is trading in the red, and is down by -1.75% at 64.02.

How has Halozyme Therapeutics Inc. performed historically?

Halozyme Therapeutics Inc. is currently trading down -1.75% on an intraday basis. In the past week the stock rose 2.81%. stock has been up 36.53% in the past quarter and rose 59.73% in the past year. You can view this in the overview section.